Molecular determinants of epothilone B derivative (BMS 247550) and Apo-2L/TRAIL-induced apoptosis of human ovarian cancer cells
- 1 April 2003
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 89 (1) , 37-47
- https://doi.org/10.1016/s0090-8258(03)00006-4
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- An Inducible Pathway for Degradation of FLIP Protein Sensitizes Tumor Cells to TRAIL-induced ApoptosisJournal of Biological Chemistry, 2002
- Identification of Omi/HtrA2 as a Mitochondrial Apoptotic Serine Protease That Disrupts Inhibitor of Apoptosis Protein-Caspase InteractionJournal of Biological Chemistry, 2002
- Synergistic Induction of Apoptosis by the Combination of TRAIL and Chemotherapy in Chemoresistant Ovarian Cancer CellsGynecologic Oncology, 2001
- Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and DeathScience, 2001
- XIAP Regulates DNA Damage-induced Apoptosis Downstream of Caspase-9 CleavageJournal of Biological Chemistry, 2000
- Smac, a Mitochondrial Protein that Promotes Cytochrome c–Dependent Caspase Activation by Eliminating IAP InhibitionCell, 2000
- Safety and antitumor activity of recombinant soluble Apo2 ligandJournal of Clinical Investigation, 1999
- An APAF-1·Cytochrome c Multimeric Complex Is a Functional Apoptosome That Activates Procaspase-9Journal of Biological Chemistry, 1999
- BAD partly reverses paclitaxel resistance in human ovarian cancer cellsOncogene, 1998
- Deoxycytidine protects normal bone marrow progenitors against Ara-C and gemcitabine cytotoxicity without compromising their activity against cisplatin-resistant human ovarian cancer cellsGynecologic Oncology, 1992